Investing Profile

Carol Gallagher

VCInvestorOperator

Venture Partner at New Enterprise Associates (NEA)

Photo of Carol Gallagher, Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
New Enterprise Associates (NEA) Partner
$50K - $50.0M
$25.0M
7
$3.6B
CompanyStageDateRound SizeTotal Raised
Pionyr Immunotherapeutics
Series BDec 2017$62M
$70.5M
Co-investors: Jack Kenney (SV Health Investors)
Metacrine
Series BDec 2017$22M
$22M
Good2Go
Seed RoundSep 2017$7M
$7M
Co-investors: Nancy Schoendorf (Mohr Davidow Ventures)
Good2Go, Inc.
Seed RoundSep 2017$7M
$7M
Co-investors: Ruby Lee (Kleiner Perkins)
Cleave Therapeutics
Series BAug 2016$26M
Series AApr 2013$10M
$36M
Co-investors: Robert Garland (New Enterprise Associates (NEA))
Millendo Therapeutics
Series BJan 2016$62M
$62M